On this episode of #ShareScience, we spoke with Dr. Rachel Buckley, Associate Professor of Neurology at Massachusetts General Hospital and Harvard Medical School. Her research interests lie in sex differences in risk for Alzheimer’s disease, and she holds multiple NIH grants seeking to optimize women’s brain health in neurodegenerative disease, with a specific focus on the role of menopause, sex hormones and the X chromosome to impact risk and resilience to Alzheimer’s disease. In this interview, she shares information on her research and why she’s passionate about women’s health.

Rachel is a speaker in our upcoming Women’s Health Series, a joint webinar series with The American Physiological Society (APS), Society for Women’s Health Research (SWHR), and InsideScientific covering late-breaking research, novel discovery, fundamental principles, and research innovation in the field of women’s health and related disease models. To learn more and register for her webinar, click here or the Associated Webinar link below!

To watch the full interview, click here.

In this episode of Expert Answers, hear Dr. Christopher Perry, Associate Professor with the School of Kinesiology and Health Science at York University and Dr. Homira Osman, Vice President of Research and Public Policy at Muscular Dystrophy Canada answer questions from a recent webinar on how the integration of clinical, industrial, and not-for-profit advocacy partners with preclinical research labs offers great potential to improve our research impact.

For more information, to watch the webinar, or access other resources, click here.

Dr. Catherine Ewen from STEMCELL Technologies answers questions from a recent webinar where she describes how to set up DC and CD8⁺ T cell co-culture experiments and assess T cell proliferation and activity.

Dr. Jack Vanden Heuvel from Penn State University and INDIGO Biosciences answers questions from a recent webinar where he discusses methodologies for predicting drug-drug interactions using in vitro assays and gene expression studies.

Travis Hardcastle from Synthego and Seth Hanson from BrainXell answer questions from a webinar where they discuss innovative applications of CRISPR and iPSCs in disease modeling and drug discovery.

Dr. Lorcan Sherry from OracleBio and Dr. Aditya Pratapa from Akoya Biosciences answer questions from a recent webinar where they present a novel workflow for analyzing multiplex immunofluorescence images.

Dr. Conor McCartin, an Account Manager specializing in Monoclonal Antibody Development at ProteoGenix, answers questions from a recent webinar where he focuses on the utilization of phage display in the development of human antibodies.

Dr. Sarah Klein, Associate Director of the Multiplex Assays Group at Cell Signaling Technology, answers questions from a recent webinar about accelerating spatial biology discoveries by 70% using SignalStar™ Multiplex IHC’s optimized, ready-to-go panels.

Matthew Silva, PhD, CEO of EMIT Imaging, answers questions from a recent webinar where he highlights the role of cryo-fluorescence tomography in advancing the field of immunotherapy research.

Dr. Jack Vanden Heuvel from INDIGO Biosciences and Penn State University answers questions from a recent webinar where he discusses the integration of cell-based bioassays and effect-based trigger values, a method that enhances water quality assessment beyond traditional approaches.